Vertex Pharmaceuticals' (VRTX) CEO Jeff Leiden on Q4 2016 Results - Earnings Call Transcript

1/26/17

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Q4 2016 Earnings Conference Call

January 25, 2017 04:30 PM ET

Executives

Michael Partridge - Vice President of Investor Relations

Jeff Leiden - Chairman, Chief Executive Officer

Ian Smith - Chief Financial Officer, Chief Operating Officer

Stuart Arbuckle - Chief Commercial Officer

Analysts

Matthew Harrison - Morgan Stanley

Geoff Meacham - Barclays

Michael Yee - RBC Capital Markets

Brian Abrahams - Jefferies

Terence Flynn - Goldman Sachs

Cory Kasimov - JPMorgan

Mark Schoenebaum - Evercore ISI

Geoffrey Porges - Leerink Partners

Alethia Young - Credit Suisse

Ying Huang - Bank of America Merrill Lynch

Phil Nadeau - Cowen and Company

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.